| Healthbridge Medical Inc | |
| 8166 Woodland Center Blvd, Tampa, Florida 33614 | |
| (813) 872-6750 |
| Name | Healthbridge Medical Inc |
|---|---|
| Organization Name | Healthbridge Medical , Inc. |
| Location | 8166 Woodland Center Blvd, Tampa, Florida 33614 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (813) 872-6750 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A treatment strategy designed to minimise the effects of accelerated repopulation using hypofractionated radiotherapy with chemotherapy is feasible for patients with stage III non-small-cell lung cancer, according to UK researchers.
Lawmakers are expected to take up tort reform when the Oregon Legislature convenes next February. To get those discussions moving, a Patient Safety and Defensive Medicine Workgroup is developing draft legislation that includes issues such as confidentiality, mediation, dispute resolution, litigation, discovery and patient safety. Disclosure - informing patients when a serious medical event has occurred in a hospital setting - is also on the table.
According to data appearing today in Circulation Cardiovascular Quality and Outcomes, patients with a common heart rhythm disorder, called atrial fibrillation, who were treated with catheter ablation using the NAVISTAR THERMOCOOL Catheter, reported markedly fewer symptoms and substantially improved quality of life than patients treated with antiarrhythmia drugs at one year.
Today, Healthcare Information and Management Systems Society and AVIA announced HX360, a new co-developed initiative. HX360 was created to improve the way that health care is delivered by both inspiring and facilitating the adoption and use of next generation (non-EHR Platform) technologies by provider organizations, in areas where health system executives are passionate to combine the right mix of resources, processes and technologies.
Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the European Commission has granted European market authorization for the medicinal product teduglutide (trade name in Europe: Revestive) as a once-daily treatment for adult patients with short bowel syndrome.
› Verified 9 days ago
| NPI Number | 1811284490 |
| Organization Name | HEALTHBRIDGE MEDICAL , INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 7882 Woodland Center Blvd, Tampa, FL 33614 |
| Phone Number | 813-872-6750 |
News Archive
A treatment strategy designed to minimise the effects of accelerated repopulation using hypofractionated radiotherapy with chemotherapy is feasible for patients with stage III non-small-cell lung cancer, according to UK researchers.
Lawmakers are expected to take up tort reform when the Oregon Legislature convenes next February. To get those discussions moving, a Patient Safety and Defensive Medicine Workgroup is developing draft legislation that includes issues such as confidentiality, mediation, dispute resolution, litigation, discovery and patient safety. Disclosure - informing patients when a serious medical event has occurred in a hospital setting - is also on the table.
According to data appearing today in Circulation Cardiovascular Quality and Outcomes, patients with a common heart rhythm disorder, called atrial fibrillation, who were treated with catheter ablation using the NAVISTAR THERMOCOOL Catheter, reported markedly fewer symptoms and substantially improved quality of life than patients treated with antiarrhythmia drugs at one year.
Today, Healthcare Information and Management Systems Society and AVIA announced HX360, a new co-developed initiative. HX360 was created to improve the way that health care is delivered by both inspiring and facilitating the adoption and use of next generation (non-EHR Platform) technologies by provider organizations, in areas where health system executives are passionate to combine the right mix of resources, processes and technologies.
Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the European Commission has granted European market authorization for the medicinal product teduglutide (trade name in Europe: Revestive) as a once-daily treatment for adult patients with short bowel syndrome.
› Verified 9 days ago
News Archive
A treatment strategy designed to minimise the effects of accelerated repopulation using hypofractionated radiotherapy with chemotherapy is feasible for patients with stage III non-small-cell lung cancer, according to UK researchers.
Lawmakers are expected to take up tort reform when the Oregon Legislature convenes next February. To get those discussions moving, a Patient Safety and Defensive Medicine Workgroup is developing draft legislation that includes issues such as confidentiality, mediation, dispute resolution, litigation, discovery and patient safety. Disclosure - informing patients when a serious medical event has occurred in a hospital setting - is also on the table.
According to data appearing today in Circulation Cardiovascular Quality and Outcomes, patients with a common heart rhythm disorder, called atrial fibrillation, who were treated with catheter ablation using the NAVISTAR THERMOCOOL Catheter, reported markedly fewer symptoms and substantially improved quality of life than patients treated with antiarrhythmia drugs at one year.
Today, Healthcare Information and Management Systems Society and AVIA announced HX360, a new co-developed initiative. HX360 was created to improve the way that health care is delivered by both inspiring and facilitating the adoption and use of next generation (non-EHR Platform) technologies by provider organizations, in areas where health system executives are passionate to combine the right mix of resources, processes and technologies.
Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the European Commission has granted European market authorization for the medicinal product teduglutide (trade name in Europe: Revestive) as a once-daily treatment for adult patients with short bowel syndrome.
› Verified 9 days ago
6th St. Bridge Mobility Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7818 Depot Ln, Tampa, Florida 33637 Phone: (813) 621-2001 | |
A-ability Medical Equipment Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4010 E Hillsborough Ave, Tampa, Florida 33610 Phone: (813) 620-4475 | |
About You Type: Prosthetic/Orthotic Supplier Location: 3401 Henderson Blvd, Tampa, Florida 33609 Phone: (813) 876-2727 | |
Advance Pharmacy Service Llc Type: Pharmacy Location: 4910 N Armenia Ave, Tampa, Florida 33603 Phone: (813) 350-9999 | |
Advocate Medical Services Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5912 Breckenridge Pkwy, Tampa, Florida 33610 Phone: (813) 280-6547 |